NDC11 67877055230
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 67877-0552-30 | 67877-0552 |
| 67877-552-30 | 67877-552 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Deferasirox | DEFERASIROX | Ascend Laboratories, LLC | 0fb210b3-6a3d-4313-83ce-52012e384f9b | 2025-06-04 | Boxed warning, Warnings, Adverse reactions | 67877-552-30 67877-552 67877055230 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.